Skip to main content

Gen-Probe Files for FDA Approval of Panther System

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe today announced it has filed for regulatory approval in the US for its Panther molecular diagnostics system.

The platform, which received CE marking in late 2010, is a fully automated and integrated molecular testing system which complements Gen-Probe's Tigris system. The company filed for 510(k) clearance from the US Food and Drug Administration to run the Aptima Combo 2.0 assay, a dual test for chlamydia and gonorrhea, on Panther. Gen-Probe added that it is developing other qualitative and quantitative assays for the system.

"Filing our US regulatory application for the Panther system on time is another important milestone in our efforts to create differentiated value for our laboratory customers," Carl Hull, president and CEO of Gen-Probe, said in a statement. "We believe the Panther system will revolutionize molecular diagnostics by offering customers high levels of productivity and instrument flexibility that were once reserved for high-throughput clinical chemistry and immunoassay systems."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.